Clinical Trials
8 trialsNCT05803941 2026-06-04
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Novartis
Phase 4 Recruiting
NCT06783348 2026-06-04
RENALUT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Recruiting
NCT07223034 2026-06-04
A Study of 177Lu-PSMA-617 in People With Gliomas
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT07226986 2026-06-03
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Novartis
Phase 1/2 Recruiting
NCT06632977 2026-06-02
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT06514521 2026-06-01
Post Marketing Study on Pluvicto in Korea
Novartis
Recruiting
NCT07145177 2026-06-01
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 1 Recruiting
NCT06574880 2026-05-26
STARLiT
Case Comprehensive Cancer Center
Phase 1/2 Recruiting